SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Reducing the risk of infection from plasma products: specific preventative strategies
2 references·12 citing·37 second hop
Reducing the risk of infection from plasma products: specific preventative strategies (2000)Reducing the risk of infection from plasm…Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting (1999)Feasibility and efficacy of r…The Risk of Transfusion-Transmitted Viral Infections (1996)The Risk of Transfusion-Trans…Impact of COVID ‐19 and lockdown regarding blood transfusion (2021)Impact of COVID ‐19 and lockd…Helping doctors hasten COVID-19 treatment: Towards a rescue framework for the transfusion of best convalescent plasma to the most critical patients based on biological requirements via ml and novel MCDM methods (2020)Helping doctors hasten COVID-…Pathogen reduction of blood components during outbreaks of infectious diseases in the European Union: an expert opinion from the European Centre for Disease Prevention and Control consultation meeting. (2019)Pathogen reduction of blood c…Prevalence and trends of hepatitis B virus, Hepatitis C virus, Human immunodeficiency virus 1, 2 and syphilis infections among blood donors in a regional transfusion center in Punjab, India: A 3 years study (2016)Prevalence and trends of hepa…“Go no Go” in plasma fractionation in the world's emerging economies: Still a question asked 70 years after the COHN process was developed! (2014)“Go no Go” in plasma fraction…Prévalence des marqueurs infectieux chez les donneurs de sang en milieu rural. Cas de l'hôpital général de référence de Kamina (2013)Prévalence des marqueurs infe…WHO RECOMMENDATIONS FOR THE PRODUCTION, CONTROL AND REGULATION OF HUMAN PLASMA FOR FRACTIONATION (2011)WHO RECOMMENDATIONS FOR THE P…Sero-epidemiology of transfusion-transmissible infectious diseases among blood donors in Osogbo, south-west Nigeria. (2009)Sero-epidemiology of transfus…Emerging viral threats to the Australian blood supply (2008)Emerging viral threats to the…Fractionnement plasmatique international : état des lieux (2007)Fractionnement plasmatique in…Residual cell content in plasma produced by three centrifugal apheresis procedures (2003)Residual cell content in plas…Protein composition and activation markers in plasma collected by three apheresis procedures (2003)Protein composition and activ…Trends in Incidence and Prevalence of Major Transfusion-Transmissible Viral Infections in US Blood Donors, 1991 to 1996 (2000)Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis infections among blood donors at the Muhimbili National Hospital in Dar Es Salaam, Tanzania (2006)The challenges of meeting the blood transfusion requirements in Sub-Saharan Africa: the need for the development of alternatives to allogenic blood (2011)Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon (2013)Seroprevalence of transfusion transmitted infection among blood donors at Jijiga blood bank, Eastern Ethiopia: retrospective 4 years study (2016)Intravenous immunoglobulin: regulatory perspectives on use and supply (2001)Economical impact of plasma fractionation project in Iran on affordability of plasma‐derived medicines (2009)Plasma-derived medicinal products self-sufficiency from national plasma: to what extent? (2013)Emerging pathogens and their implications for the blood supply and transfusion transmitted infections (2012)External Financial Aid to Blood Transfusion Services in Sub-Saharan Africa: A Need for Reflection (2012)Should Blood Be an Essential Medicine? (2013)Challenges associated with access to plasma‐derived medicinal products in low middle‐income and low‐income countries (2023)Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus (2005)Emerging Infectious Diseases That Threaten the Blood Supply (2006)Transfusion-transmitted infections (2007)Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States (1995)Nucleic acid amplification testing of blood donors fortransfusion‐transmitted infectious diseases (2000)Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus (2008)International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009 (2011)Current perspectives in transfusion‐transmitted infectious diseases: emerging and re‐emerging infections (2014)Assessing risks of infection with herpes viruses during transfusion of donor blood and its components (2020)Mitigating the risk of transfusion‐transmitted infections with vector‐borne agents solely by means of pathogen reduction (2022)Extended VIKOR method in comparison with outranking methods (2006)Best-worst multi-criteria decision-making method (2014)Supplier selection among SMEs on the basis of their green innovation ability using BWM and fuzzy TOPSIS (2017)Determining Importance of Many-Objective Optimisation Competitive Algorithms Evaluation Criteria Based on a Novel Fuzzy-Weighted Zero-Inconsistency Method (2021)Evaluation of government strategies against COVID-19 pandemic using q-rung orthopair fuzzy TOPSIS method (2021)The applications of MCDM methods in COVID-19 pandemic: A state of the art review (2022)COVID-19 transmission and blood transfusion: A case report (2020)Effects of the COVID-19 pandemic on supply and use of blood for transfusion (2020)La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19 (2020)The impact of blood campaigns using mobile blood collection drives on blood supply management during the COVID-19 pandemic (2022)Impact of natural disasters and pandemics on blood supply: A systematic review (2023)Impact of the COVID-19 Pandemic on Blood Donation Patterns: A Systematic Review and Meta-Analysis (2023)Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)
this work references cited by second hop

References

  • 1996The Risk of Transfusion-Transmitted Viral Infections1,865 cited
  • 1999Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting254 cited

Cited by

  • 2009Sero-epidemiology of transfusion-transmissible infectious diseases among blood donors in Osogbo, south-west Nigeria.194 cited
  • 2020Helping doctors hasten COVID-19 treatment: Towards a rescue framework for the transfusion of best convalescent plasma to the most critical patients based on biological requirements via ml and novel MCDM methods102 cited
  • 2008Emerging viral threats to the Australian blood supply34 cited
  • 2019Pathogen reduction of blood components during outbreaks of infectious diseases in the European Union: an expert opinion from the European Centre for Disease Prevention and Control consultation meeting.28 cited
  • 2003Protein composition and activation markers in plasma collected by three apheresis procedures25 cited
  • 2007Fractionnement plasmatique international : état des lieux22 cited
  • 2021Impact of COVID ‐19 and lockdown regarding blood transfusion21 cited
  • 2014“Go no Go” in plasma fractionation in the world's emerging economies: Still a question asked 70 years after the COHN process was developed!18 cited
  • 2013Prévalence des marqueurs infectieux chez les donneurs de sang en milieu rural. Cas de l'hôpital général de référence de Kamina16 cited
  • 2003Residual cell content in plasma produced by three centrifugal apheresis procedures

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

16 cited
  • 2016Prevalence and trends of hepatitis B virus, Hepatitis C virus, Human immunodeficiency virus 1, 2 and syphilis infections among blood donors in a regional transfusion center in Punjab, India: A 3 years study11 cited
  • 2011WHO RECOMMENDATIONS FOR THE PRODUCTION, CONTROL AND REGULATION OF HUMAN PLASMA FOR FRACTIONATION11 cited